A successful first launch is critical to a biopharma organization’s success—and implementing a carefully considered strategy can have long-lasting effects. In this webinar, we explore U.S. first launch trends from 2011-2024. We look at U.S. novel biopharma first launches and their choices for go-it-alone or co-copromotion, as well as their partnering strategies for Europe. We’ll share performance metrics and key spend and field sizing benchmarks for all recent first launches, with a spotlight on oncology, rare disease and central nervous system.
Watch this webinar to get:
- A review of more than a decade of U.S. first launches, including their EU commercialization strategies
- Perspective on emerging better practices, including cloud solutions, AI and omnichannel
- A look at the evolution of the commercial model
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
